Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT05345808
Eligibility Criteria:
Inclusion Criteria:
* Diminution of vision due to macular edema secondary to non-ischemic retinal vein occlusions, either central or branch
* CMT ≥ 250 µ,
* Willing to participate in the study.
Exclusion Criteria:
* Unwilling to participate in the study
* Ischemic RVO
* previous laser treatment
* Glaucoma, macular ischemia, cataract, vitreous hemorrhage, and neovascularization of the iris
* patients with previous anti VEGFs or steroid injections or any eye surgery three months before the inclusion
* Cardiac co-morbidities result in significant hemodynamic changes
* Respiratory diseases need treatment with antibiotics
* Suffering from other chronic diseases as diabetes
* Patient with allergy from triamcinolone acetonide.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
69 Years
Study:
NCT05345808
Study Brief:
Protocol Section:
NCT05345808